Success Metrics

Clinical Success Rate
85.7%

Based on 12 completed trials

Completion Rate
86%(12/14)
Active Trials
7(23%)
Results Posted
67%(8 trials)
Terminated
2(6%)

Phase Distribution

Ph early_phase_1
2
6%
Ph not_applicable
6
19%
Ph phase_2
5
16%
Ph phase_4
4
13%
Ph phase_1
9
29%

Phase Distribution

11

Early Stage

5

Mid Stage

4

Late Stage

Phase Distribution26 total trials
Early Phase 1First-in-human
2(7.7%)
Phase 1Safety & dosage
9(34.6%)
Phase 2Efficacy & side effects
5(19.2%)
Phase 4Post-market surveillance
4(15.4%)
N/ANon-phased studies
6(23.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

63.2%

12 of 19 finished

Non-Completion Rate

36.8%

7 ended early

Currently Active

7

trials recruiting

Total Trials

31

all time

Status Distribution
Active(7)
Completed(12)
Terminated(7)
Other(5)

Detailed Status

Completed12
Recruiting6
unknown5
Withdrawn5
Terminated2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
31
Active
7
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (7.7%)
Phase 19 (34.6%)
Phase 25 (19.2%)
Phase 44 (15.4%)
N/A6 (23.1%)

Trials by Status

active_not_recruiting13%
terminated26%
unknown516%
recruiting619%
withdrawn516%
completed1239%

Recent Activity

Clinical Trials (31)

Showing 20 of 31 trialsScroll for more
NCT03154996Phase 1

Chronic Convection Enhanced Delivery of Topotecan

Completed
NCT02390635Phase 1

PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia

Recruiting
NCT05692635Phase 2

Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance

Recruiting
NCT03067467

Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)

Recruiting
NCT03270059Phase 2

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Recruiting
NCT02648009Phase 1

Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection

Recruiting
NCT04474353Phase 1

Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

Completed
NCT04727242Phase 2

CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma

Active Not Recruiting
NCT05783271Not Applicable

Validity of Parametric MRI Using VIRADS

Recruiting
NCT04809584

18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer

Unknown
NCT03565367Phase 1

Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbonate in Participants With Central Nervous System Tumors

Completed
NCT00659126Phase 2

Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors

Terminated
NCT00978562Early Phase 1

DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors

Completed
NCT00103038Not Applicable

Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases

Completed
NCT02163005Phase 4

A Feasibility Study to Assess the Use of Gadolinium in Computed Tomography

Withdrawn
NCT02598674

Severe Sepsis in Children - IMPRESS-C

Withdrawn
NCT02530931Phase 4

Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease

Terminated
NCT02783768Early Phase 1

Ventilation and Pulmonary Endothelium Toxicities of E-cigarettes: A Randomized Crossover Pilot Study

Completed
NCT02599844

Impact of Pediatric Acute Renal Injury in Severe Sepsis in Young Adults

Withdrawn
NCT02234375Phase 4

Use of Gadolinium in CT Pulmonary Angiography

Withdrawn

Drug Details

Intervention Type
DRUG
Total Trials
31